+46 8 524 860 70
+46 8 524 860 70

March 12, 2016
Karolinska Development's portfolio company, Dilaforette, recently entered into an collaboration agreement with Arabian Gulf University (AGU) for phase-two clinical development of sevuparin for sickle cell disease.
Read more →
Sign-up for the Weekly Newsletter from Gulf News Journal.